Literature DB >> 26556492

[Guideline thyroid cancer including diagnostics of the nodule].

Thera P Links1, L J M Loek de Heide, Marcel Janssen, Francien H van Nederveen, Aad van der Lugt, Menno R Vriens, Johannes W A Smit.   

Abstract

Thyroid cancer is comparatively rare. Thyroid nodules, on the other hand, are frequently diagnosed as a result of increasing use of diagnostic imaging. Cytological investigation of small nodules that have been found by chance often reveals micropapillary carcinoma that is probably not clinically relevant. The new guideline 'Thyroid cancer' advises that cytological investigation of these non-palpable, incidentally discovered thyroid nodules should only be performed on indication. The standard treatment for patients with papillary or follicular thyroid cancer consists of thyroidectomy followed by, if indicated, lymph-node dissection, ablation therapy with radioactive iodine and TSH-suppression. The extent of this treatment is determined on the basis of known prognostic factors and the results of initial treatment. Targeted systemic therapy is available for patients with metastatic progressive disease. There is more focus on the effects of short- and long-term treatment, in order to optimise quality of life.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26556492

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  Surgical Complications and Referral Patterns in 567 Patients with Differentiated Thyroid Cancer in the Northern Region of the Netherlands: A Population-Based Study Towards Clinical Management Implementation.

Authors:  Deborah van Dijk; Boukje A C van Dijk; Annemieke Weistra; Thera P Links; John Th M Plukker
Journal:  Ann Surg Oncol       Date:  2020-04-23       Impact factor: 5.344

2.  TIPE2 acts as a biomarker for tumor aggressiveness and suppresses cell invasiveness in papillary thyroid cancer (PTC).

Authors:  Wenyu Jia; Zequn Li; Junyu Chen; Lei Sun; Chuanqian Liu; Shaping Wang; Jingwei Chi; Jun Niu; Hong Lai
Journal:  Cell Biosci       Date:  2018-08-31       Impact factor: 7.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.